Brought to you by 
Inverness is buying HemoSense for $171.6mm in stock
07 Nov 2007
Executive Summary
Inverness Medical Innovations will acquire point-of-care testing company HemoSense for $171.6mm in stock or 10.5 times HemoSense's 2006 revenues.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
Medical Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Hematology, Coagulation
- Therapeutic Drug Monitoring
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inverness is buying HemoSense for $171.6mm in stock
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice